NCT06740019View on ClinicalTrials.gov

A Phase Ib Study of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion

PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 28, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

November 30, 2026

Conditions
Malignant Pleural Effusions (Mpe)
Interventions
DRUG

JMKX000197

for pleural perfusion

PROCEDURE

Tube thoracostomy drainage

Tube thoracostomy drainage

Trial Locations (1)

100017

RECRUITING

Cancer Hospital, Chinese Academy of Medical Sciences, Beijing

Sponsors

Lead Sponsor

Jemincare
All Listed Sponsors
lead

Jemincare

INDUSTRY

NCT06740019 - A Phase Ib Study of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion | Biotech Hunter | Biotech Hunter